Pugatch Consiliumhttp://www.pugatch-consilium.com
Innovation • Technology Transfer • Intellectual Property • Market AccessMon, 11 Feb 2019 15:03:07 +0000en-UShourly1https://wordpress.org/?v=4.9.9The EU Orphan Regulation: A success story in driving R&D of orphan medicines in the EU – but what about access?http://www.pugatch-consilium.com/?p=2708
Sun, 10 Feb 2019 23:32:47 +0000http://www.pugatch-consilium.com/?p=2708
Within the context of the European Commission’s Evaluation of the legislation on medicines for children and rare diseases, the study examines whether the EU Orphan Regulation has accomplished its aim of incentivising the development and introduction of new therapies for rare diseases onto the EU market, and explores some of the current ...]]>Positioning Ireland as a global innovation leader in the 4th Industrial Revolutionhttp://www.pugatch-consilium.com/?p=2697
Mon, 19 Nov 2018 21:02:12 +0000http://www.pugatch-consilium.com/?p=2697
In the field of professional boxing, Ireland was and remains a global superpower and a role model. Yet in the field of biopharmaceutical innovation, Ireland does not step into the ring of greats:

Despite retaining the reputation of a global leader in advances biopharmaceutical manufacturing – with €10 billion invested over the ...]]>New Pugatch Consilium Study Shows How Countries Can Develop Biotech Industryhttp://www.pugatch-consilium.com/?p=2685
Mon, 19 Nov 2018 08:00:04 +0000http://www.pugatch-consilium.com/?p=2685
The fifth edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators ranging from public policy inputs to biotechnology outputs, the report provides a full and ...]]>Leveraging Resources to Generate Outputs and Lead the Global Biotech Innovation – Policy is Key!http://www.pugatch-consilium.com/?p=2664
Mon, 11 Jun 2018 14:39:51 +0000http://www.pugatch-consilium.com/?p=2664
Earlier last week Professor Meir Pugatch moderated the Global Leadership Forum at the BIO International Convention that was held at Boston, MA. The panel, titled “Can Boston’s ...]]>A New Era For Russian Biotechnology In 2030 – Remains To Be Seen And Provenhttp://www.pugatch-consilium.com/?p=2657
Mon, 28 May 2018 15:04:59 +0000http://www.pugatch-consilium.com/?p=2657Daniel Coriat Sharing the Results of the BCI 2017 | Hosted by the CIFhttp://www.pugatch-consilium.com/?p=2651
Wed, 16 May 2018 17:14:15 +0000http://www.pugatch-consilium.com/?p=2651
http://www.infinita.cl/entrevistas/2018/05/09/daniel-coriat-director-consultora-pugatch-consilium
]]>Is Taiwan Ready for the Top Spot?http://www.pugatch-consilium.com/?p=2637
Thu, 26 Apr 2018 14:02:19 +0000http://www.pugatch-consilium.com/?p=2637
Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to and remaining challenges in Taiwan’s path to leadership in global biotech innovation.
By utilizing a competitive mentality that views policy as instrumental in achieving economic ...]]>Daniel Coriat on Colombia’s standing in the BCI reporthttp://www.pugatch-consilium.com/?p=2628
Mon, 09 Apr 2018 12:34:09 +0000http://www.pugatch-consilium.com/?p=2628
Listen to the interview
]]>Towards a Sustainable European Market for Off-Patent Biologicshttp://www.pugatch-consilium.com/?p=2621
Wed, 07 Mar 2018 13:57:05 +0000http://www.pugatch-consilium.com/?p=2621
With 38 biosimilar medicines approved and marketed and hundreds of clinical trials ...]]>2017 BCI and Mexico’s Competitivenesshttp://www.pugatch-consilium.com/?p=2616
Thu, 08 Feb 2018 23:28:04 +0000http://www.pugatch-consilium.com/?p=2616
Read the 2017 BCI report at: Research & Analysis Reports Page
]]>